Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings

Alejandra Maciel, Ali Cullors, Andrew A Lukowiak, Jorge Garces AltheaDx, San Diego, CA, USA Abstract: The burden of depression significantly impacts the patient, the health care system, and society, at large. Medication management guided by pharmacogenetics has been shown to increase therapeutic e...

Full description

Bibliographic Details
Main Authors: Maciel A, Cullors A, Lukowiak AA, Garces J
Format: Article
Language:English
Published: Dove Medical Press 2018-01-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Pharmacogenetics
depression
personalized medicine
cost-savings
pharmacoeconomics
psychotropic
cytochrome P450
Online Access:https://www.dovepress.com/estimating-cost-savings-of-pharmacogenetic-testing-for-depression-in-r-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/estimating-cost-savings-of-pharmacogenetic-testing-for-depression-in-r-peer-reviewed-article-NDT

Similar Items